A detailed history of Intech Investment Management LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 45,397 shares of DAWN stock, worth $319,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,397
Previous 51,164 11.27%
Holding current value
$319,594
Previous $405,000 27.16%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$6.16 - $7.97 $35,524 - $45,962
-5,767 Reduced 11.27%
45,397 $295,000
Q1 2025

May 20, 2025

BUY
$7.93 - $13.21 $129,068 - $215,005
16,276 Added 46.65%
51,164 $405,000
Q4 2024

Feb 10, 2025

BUY
$12.46 - $16.39 $145,183 - $190,976
11,652 Added 50.15%
34,888 $442,000
Q3 2024

Nov 08, 2024

BUY
$12.72 - $16.03 $295,561 - $372,473
23,236 New
23,236 $323,000

Others Institutions Holding DAWN

About Day One Biopharmaceuticals, Inc.


  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $517M
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.